Adderall 30 vs. Vyvanse: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Adderall 30 and Vyvanse. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 120,621 people who take Adderall 30 and Vyvanse, and is updated regularly.
What is Adderall 30?
Adderall 30 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 2,045 Adderall 30 users. Check the latest studies of Adderall 30.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
120,621 people who take Adderall 30 and Vyvanse are studied.
Drugs being compared in this study:
- Vyvanse (lisdexamfetamine dimesylate)
- Adderall 30 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Adderall 30:
- not at all: 1.22 %
- somewhat: 11.21 %
- moderate: 32.69 %
- high: 39.29 %
- very high: 15.59 %
Vyvanse:
- not at all: 1.94 %
- somewhat: 11.62 %
- moderate: 32.85 %
- high: 38.99 %
- very high: 14.61 %
Want to compare Adderall 30 with Vyvanse?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Adderall 30 (298 reports)
- Vyvanse (28,085 reports)
Browse all side effects of Adderall 30:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate and lisdexamfetamine dimesylate (the active ingredients of Adderall 30 and Vyvanse, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Afinitor and Probiotics - 7 seconds ago
- How effective is Symbicort for Athsma? - 7 seconds ago
- Cefzil vs. Doxycycline, side effect and effectiveness comparison - 8 seconds ago
- Drug interactions of Timoptic and Trusopt - 16 seconds ago
- Could Accupril cause Fluid Retention? - 27 seconds ago
- Drug interactions of Adrenalin and Oxycodone - 40 seconds ago
- Could Pradaxa cause Urinary Retention? - 43 seconds ago
- Could Genvoya cause Cough Aggravated? - a minute ago
- Could Valium cause Dependence? - a minute ago
- Gastroesophageal Reflux Disease and Blood Bicarbonate Decreased - a minute ago